Quarterly report pursuant to Section 13 or 15(d)

Share-Based Payments - Restricted Stock Activity (Details)

v3.25.0.1
Share-Based Payments - Restricted Stock Activity (Details)
 3 Months Ended
Dec. 31, 2024
$ / shares
shares
Restricted Stock  
RSUs  
Non-vested at beginning of period (in shares) 1,707,349
Granted (in shares) 520,900
Contingent grant (in shares) 145,800
Vested (in shares) (423,295)
Expired or forfeited (in shares) (119,240)
Non-vested at end of period (in shares) 1,831,514
Weighted- average Grant-date Fair Value  
Non-vested weighted-average grant-date fair value, beginning of period (in dollars per share) | $ / shares $ 33.59
Granted, weighted-average grant-date fair value (in dollars per share) | $ / shares 25.52
Vested, weighted-average grant-date fair value (in dollars per share) | $ / shares 37.69
Contingent grant (in dollars per share) | $ / shares 25.45
Expired or forfeited, weighted-average grant-date fair value (in dollars per share) | $ / shares 38.00
Non-vested weighted-average grant-date fair value, end of period (in dollars per share) | $ / shares $ 27.38
Time-Based Restricted Share Units  
RSUs  
Contingent grant (in shares) 58,320
Performance-Based Restricted Share Units  
RSUs  
Contingent grant (in shares) 43,740
Stock Appreciation Rights (SARs)  
RSUs  
Contingent grant (in shares) 43,740